Vamotinib
Vamotinib (PF-114) is an orally active and specific tyrosine kinase inhibitor with antiproliferative and antitumour activity.Vamotinib inhibits the phosphorylation of BCR/ABL and BCR/ABL-T315I, which promotes apoptosis. Vamotinib is used to study drug-resistant Philadelphia chromosome-positive (Ph+) leukaemia and Alzheimer's disease.
Product Specifications
CAS Number
1416241-23-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
532.56
Molecular Formula
C29H27F3N6O
Notes
Research use only, not for human use.
Receptor
Bcr-Abl | Apoptosis | Tyrosine Kinases
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
C2399-08A-APC 100 µL
CD45 (CD45 Antigen, B220, GP180, Leukocyte Common Antigen, LCA, L-CA, LY5, LY-5, Protein Tyrosine Phosphatase Receptor Type C, Protein Tyrosine Phosphatase Receptor Type C Polypeptide, PTPRC, T200, T200 Glycoprotein) (APC) discontinued
Sign In for Pricing
View Details 
JGC43163-01 50 mg
2- (4-Chloro-3-fluorophenyl) -1-methyl-5-oxopyrrolidine-3-carboxylic acid
Sign In for Pricing
View Details JGC43163-02 0.5 g
2- (4-Chloro-3-fluorophenyl) -1-methyl-5-oxopyrrolidine-3-carboxylic acid
Sign In for Pricing
View Details